H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 88 Citations 31,394 255 World Ranking 6442 National Ranking 277

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Enzyme

Richard B. Kim spends much of his time researching Pharmacology, Pharmacokinetics, Genetics, Internal medicine and Genotype. His Pharmacology research integrates issues from Organic anion transporter 1, Organic anion-transporting polypeptide and Transporter. His study focuses on the intersection of Pharmacokinetics and fields such as Adverse effect with connections in the field of Xenobiotic transport, Metabolite, Volume of distribution and Chlorzoxazone.

His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology, CYP3A5 and Immunology. His research investigates the connection between Genotype and topics such as Allele that intersect with problems in CYP2C9 and Exon. Richard B. Kim has researched Haplotype in several fields, including Single-nucleotide polymorphism and Genetic variation.

His most cited work include:

  • Membrane transporters in drug development. (2257 citations)
  • The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. (987 citations)
  • Identification of functionally variant MDR1 alleles among European Americans and African Americans (902 citations)

What are the main themes of his work throughout his whole career to date?

Richard B. Kim mainly focuses on Pharmacology, Internal medicine, Transporter, Pharmacokinetics and Endocrinology. His work carried out in the field of Pharmacology brings together such families of science as Organic anion transporter 1, Organic anion-transporting polypeptide, Pharmacogenetics and In vivo. His Internal medicine study incorporates themes from Gastroenterology, Oncology and Genotype.

His Transporter research is classified as research in Biochemistry. His Pharmacokinetics research incorporates themes from Oral administration, Fexofenadine and Bioavailability. His studies deal with areas such as Receptor and Polymorphism as well as Endocrinology.

He most often published in these fields:

  • Pharmacology (42.57%)
  • Internal medicine (32.18%)
  • Transporter (17.33%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (32.18%)
  • Oncology (7.92%)
  • Pharmacology (42.57%)

In recent papers he was focusing on the following fields of study:

Richard B. Kim mainly investigates Internal medicine, Oncology, Pharmacology, Pharmacogenetics and Gastroenterology. The concepts of his Internal medicine study are interwoven with issues in Endocrinology and Genotype. His biological study spans a wide range of topics, including Organic anion-transporting polypeptide and In vivo.

His work deals with themes such as Fexofenadine and Midazolam, which intersect with In vivo. His Pharmacogenetics research is multidisciplinary, relying on both Precision medicine and CYP2C9. The Pharmacokinetics study which covers Apixaban that intersects with CYP3A5 and Anesthesia.

Between 2015 and 2021, his most popular works were:

  • Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands (298 citations)
  • Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events (83 citations)
  • Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance (72 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Enzyme

His scientific interests lie mostly in Internal medicine, Pharmacology, Pharmacogenetics, Adverse effect and Oncology. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Endocrinology. His Pharmacology research is multidisciplinary, incorporating elements of Potency, Ticagrelor, Vascular reactivity, Organic anion-transporting polypeptide and In vivo.

Richard B. Kim has included themes like Fexofenadine, Rosuvastatin, Cmax and Grapefruit juice in his Organic anion-transporting polypeptide study. His In vivo research incorporates elements of Pharmacokinetics, Anthracycline, ATP-binding cassette transporter, Intestinal absorption and Organic anion transporter 1. Richard B. Kim combines subjects such as Genotyping, Pharmacogenomics and Genetic variation with his study of Pharmacogenetics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Membrane transporters in drug development.

Kathleen M. Giacomini;Shiew Mei Huang;Donald J. Tweedie;Leslie Z. Benet.
Nature Reviews Drug Discovery (2010)

2798 Citations

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

R. B. Kim;M. F. Fromm;C. Wandel;B. Leake.
Journal of Clinical Investigation (1998)

1269 Citations

Identification of functionally variant MDR1 alleles among European Americans and African Americans

Richard B. Kim;Richard B. Kim;Brenda F. Leake;Brenda F. Leake;Edna F. Choo;Edna F. Choo;George K. Dresser;George K. Dresser.
Clinical Pharmacology & Therapeutics (2001)

1238 Citations

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.

Catia Marzolini;Catia Marzolini;Erik Paus;Erik Paus;Thierry Buclin;Thierry Buclin;Richard B. Kim;Richard B. Kim.
Clinical Pharmacology & Therapeutics (2004)

1160 Citations

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

David W Haas;Heather J Ribaudo;Richard B Kim;Camlin Tierney.
AIDS (2004)

732 Citations

Genetic determinants of response to warfarin during initial anticoagulation.

Ute I. Schwarz;Marylyn D. Ritchie;Yuki Bradford;Chun Li.
The New England Journal of Medicine (2008)

726 Citations

Molecular basis of ethnic differences in drug disposition and response.

Hong-Guang Xie;Richard B Kim;Alastair Jj Wood;C Michael Stein.
Annual Review of Pharmacology and Toxicology (2001)

703 Citations

OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine

Mirjana Cvetkovic;Brenda Leake;Martin F. Fromm;Grant R. Wilkinson.
Drug Metabolism and Disposition (1999)

694 Citations

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans.

Rommel G. Tirona;Brenda F. Leake;Gracia Merino;Richard B. Kim.
Journal of Biological Chemistry (2001)

676 Citations

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.

George K. Dresser;George K. Dresser;George K. Dresser;David G. Bailey;David G. Bailey;David G. Bailey;Brenda F. Leake;Brenda F. Leake;Brenda F. Leake;Ute I. Schwarz;Ute I. Schwarz;Ute I. Schwarz.
Clinical Pharmacology & Therapeutics (2002)

661 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Richard B. Kim

Yuichi Sugiyama

Yuichi Sugiyama

University of Tokyo

Publications: 155

Hiroyuki Kusuhara

Hiroyuki Kusuhara

University of Tokyo

Publications: 96

Martin F. Fromm

Martin F. Fromm

University of Erlangen-Nuremberg

Publications: 94

Matthias Schwab

Matthias Schwab

University of Tübingen

Publications: 91

Jos H. Beijnen

Jos H. Beijnen

Antoni van Leeuwenhoek Hospital

Publications: 86

Mikko Niemi

Mikko Niemi

University of Helsinki

Publications: 77

David Back

David Back

University of Liverpool

Publications: 71

Alex Sparreboom

Alex Sparreboom

The Ohio State University

Publications: 69

Kathleen M. Giacomini

Kathleen M. Giacomini

University of California, San Francisco

Publications: 66

Ikumi Tamai

Ikumi Tamai

Kanazawa University

Publications: 66

Pertti J. Neuvonen

Pertti J. Neuvonen

University of Helsinki

Publications: 65

David W. Haas

David W. Haas

Vanderbilt University

Publications: 62

Bruno Stieger

Bruno Stieger

University of Zurich

Publications: 62

Saye Khoo

Saye Khoo

University of Liverpool

Publications: 61

Sean Ekins

Sean Ekins

University of Arizona

Publications: 58

Jan H.M. Schellens

Jan H.M. Schellens

Utrecht University

Publications: 57

Something went wrong. Please try again later.